Monitoring HIV treatment in the developing world.
- 1 November 2002
- journal article
- reflection and-reaction
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 2 (11), 656-657
- https://doi.org/10.1016/s1473-3099(02)00435-8
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Total Lymphocyte Count (TLC) Is a Useful Tool for the Timing of Opportunistic Infection Prophylaxis in India and Other Resource-Constrained CountriesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- Cheaper HIV drugs for poor nations bring a new challenge: monitoring treatment.JAMA, 2002
- Antiretroviral Treatment for Adult HIV Infection in 2002JAMA, 2002
- Comparison of an Assay Using Signal Amplification of the Heat-Dissociated p24 Antigen with the Roche Monitor Human Immunodeficiency Virus RNA AssayJournal of Clinical Microbiology, 2002
- British HIV Association (BHIVA) guidelines for the treatment of HIV‐infected adults with antiretroviral therapyHIV Medicine, 2001
- Highly Active Antiretroviral Therapy Associated with Improved Anemia Among HIV-Infected WomenAIDS Patient Care and STDs, 2001
- Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO/UNAIDS recommendationsAIDS, 2001
- Evaluation of the FACScount, TRAx CD4 and Dynabeads methods for CD4 lymphocyte determinationJournal of Immunological Methods, 1996